国家: 台湾
语言: 中文
来源: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
SIMVASTATIN
台灣山德士藥業股份有限公司 臺北市中山區民生東路3段2號8樓 (90003886)
C10AA01
膜衣錠
SIMVASTATIN (2406002900) MG
鋁箔盒裝
製 劑
須由醫師處方使用
Sandoz Grup Saglik Urunleri Ilaclari San. ve Tic. A.S. GOSB Ihsan Dede Cad. 900 Sok. TR-41400 Gebze-Kocaeli, Turkey TR
simvastatin
高膽固醇血症,高三酸甘油脂血症,降低冠心病高危險群或冠心病患者的心血管事件發生率及冠心病致死率、患有異核質家族性高膽固醇血症的兒童病人。
有效日期: 2029/05/03; 英文品名: SIMVAHEXAL FILM-COATED TABLETS 20MG
2004-05-03
Simvahexal ® (simvastatin) ᣅ が ⍦ ߗ ⷑ ԵŊ ᮫ ߭ 㓪 Ⓥ ( Aspergillus terreus ) ʠᱹⷅᮟໞ≟വȯ Simvastatin ᣅᤀᙙඖʠҙⷁŊםሺരᖛ⤟ᣅҢ Ĩ - ᖕᖒ ࠣ ೣř ᔍ ᣅ Ң ʙ ˩ ⨀ Ŋ ʈ ᣅ 3-hydroxy-3-methylglutaryl- coenzyme A, HMG-CoA ⴒ׆ⷅ₪ʠ༸ӼԵřᔍⷅ₪⪭⪸Аջ ⍦ߗⷑᮝໞʠᅽቅᔎ㊾ŊҢˇᣅⳌ᪓ᗉહᔎ㊾ȯͩ⎈ಉᶇἄ ㆴḻ simvastatin ଃᯌࠣઈ (heterozygous) ᅭඖד ᅭඖ㋧⍦ߗⷑ⠐᯽Ŋᛜࠣ㋧⠐⋵᯽᯼෧Ң⍦ߗⷑ⳧㋧ʈ܈ ᩸˫㇞㇔Ӽᄓኞʃ̈́≛Ŋרሷᄓが̥Ңⅶ⠐ួ⍦ߗⷑ (total plasma cholesterol; total-C) Ȯ̥ಙ⋵⛵ᱺ⍦ߗⷑ (low-density lipoprotein cholesterol; LDL-C) Ȯ ɿ ᮙ ᗴ ⷁ (triglycerid es; TG) דᏎ̥ಙ⋵⛵ᱺ⍦ߗⷑ (very-low-density lipoprotein cholesterol; VLDL-C) ʏ֗㋧㋧ಙ⋵⛵ᱺ⍦ߗⷑ (HDL-C) ಙȯ˫ Simvahexal ® ᗶ᱗Ŋʷⳕҙ֯רവӷㆴ┮᱗ᄓŊ߈⎏Ҟ ⳕര֯Ⳮሱ̈́᱗ᄓȯྃ↲ᗶ᱗͵רℋྃ⎈ಉト᱗ᄓȯᯍϟ ᔋ˫ Simvahexal ® ᗶ᱗ᆹŊ⠐ʑ⍦ߗⷑُ⠐⋵בߊӷቍᗶ᱗ᆹ ᱿ಙȯ Simvastatin ʠ ᙙ ඖ ࠣ ᣅ HMG-CoA ⴒ ׆ ⷅ ₪ ʠ ૾ ɺ ඖ ༸ ӼԵřᔍ HMG-CoA ⴒ׆ⷅ₪⪭⪸Аջ HMG-CoA Ⱨဘໞ mevalonate ȯߌ HMG-CoA Ⱨဘໞ mevalonate ᣅ⍦ߗⷑᮝ ໞⳂലʠᅽቅᔎ㊾ŊߌᔍŊ˫ simvastatin ᗶ᱗ʏʃሳߌᶶ⋵ⷑ ㆩ╸Ử≟೧⬚ר⋱ʠᕕඖȯᔍकŊ HMG-CoA ʬૌᆞו˩⨀ ໞʨⷮⰿⷅ₪ A (acetyl-CoA) ŊҢרא⎞㋤ҙ⥓घᮝໞⳂലȯ ߱ՒᶇἄʑŊ simvasta tin ᅠםሺരŊଃ⊴⎀ң㋧ಙⴆႹඖŊ ߱ᔍҢಙᕗᐻ᱿ↈᣅ㋧ȯ Simvastatin ߱ʙ̳ᮢⵒ̤ƞ ⊴⎀ೊᘒʠ㈪᛬ (¿rst pass) ᄓະ˩⨀രŊらര֯ᗿᅠ⍦ᖢ ʑȯ߱ːㆩ⠐ʑ simvastatin ᙙඖࠣೣ᱿Қ⯿ሀヮ⸇ଅᅠםሺ Ե⸇᱿ 5% ŊҢʑ 95% ⎞ːㆩ⠐ួ⛵ᱺȯ ռ ᓿ ᅗ ࢄ ߸ ℋ ˁ ֚ Simvastatin એ ᙙ ᪓ ʠ ᶇ ἄ ʑ (Scandinavian Simvastatin Survival Study: 4S) Ŋᅠ 4444 ̤෧ ሷҴᨊՒ⋸ൔ⎀᯼ (CHD) Ŋʈⅶ㋤⍦ߗⷑϊ߱ 阅读完整的文件